Gene-activated Bone Substitute for Maxillofacial Bone Regeneration

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 6, 2017

Primary Completion Date

December 14, 2018

Study Completion Date

December 14, 2018

Conditions

Bone CystsBone AtrophyBone DeformityBone FractureBone LossTooth Loss

Interventions

DEVICE

Gene-activated matrix (OCP + plasmid DNA with VEGF gene)

Bone grafting procedure with investigated medical device

Trial Locations (1)

A.I. Moscow State University of Medicine and Dentistry, Moscow

All Listed Sponsors

collaborator

Moscow State University of Medicine and Dentistry

OTHER

lead

Histograft Co., Ltd.

INDUSTRY

NCT03076138 - Gene-activated Bone Substitute for Maxillofacial Bone Regeneration | Biotech Hunter | Biotech Hunter